dc.contributor.author | Smith, Tim A D | |
dc.date.accessioned | 2010-10-19T12:08:38Z | |
dc.date.available | 2010-10-19T12:08:38Z | |
dc.date.issued | 2010-01 | |
dc.identifier | 2893490 | |
dc.identifier | cf2b76fe-e770-417f-bff7-86fbc2ad6dab | |
dc.identifier | 72449143571 | |
dc.identifier.citation | Smith , T A D 2010 , ' Influence of chemoresistance and p53 status on fluoro-2-deoxy-D-glucose incorporation in cancer ' , Nuclear Medicine and Biology , vol. 37 , no. 1 , pp. 51-55 . https://doi.org/10.1016/j.nucmedbio.2009.08.007 | en |
dc.identifier.issn | 0969-8051 | |
dc.identifier.uri | http://hdl.handle.net/2164/774 | |
dc.format.extent | 5 | |
dc.format.extent | 85504 | |
dc.language.iso | eng | |
dc.relation.ispartof | Nuclear Medicine and Biology | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | radionuclide study | en |
dc.subject | treatment | en |
dc.subject | cancer | en |
dc.subject | 2-deoxy-2-fluoroglucose | en |
dc.subject | chemotherapy | en |
dc.subject | antineoplastic agent | en |
dc.subject | mutation | en |
dc.subject | p53 protein | en |
dc.subject | prognosis | en |
dc.subject | predictive factor | en |
dc.subject | human | en |
dc.subject | incorporation | en |
dc.subject | treatment resistance | en |
dc.subject | positron emission tomography | en |
dc.subject | emission tomography | en |
dc.subject | malignant tumor | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Influence of chemoresistance and p53 status on fluoro-2-deoxy-D-glucose incorporation in cancer | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1016/j.nucmedbio.2009.08.007 | |